Paul A Glossop (Paul Glossop)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

High Throughput

Combination Therapy

Infectious Diseases

Top Venues

Journal of medicinal chemistry

ACS infectious diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul A Glossop, James E J Mills, Gavin Whitlock, Rob Hooft van Huijsduijnen, Alessandra Monaco, Graeme Bilbe, Charles Mowbray, Benjamin Perry, Anna Adam, Timothy N C Wells, Paul A Willis
The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks. ACS infectious diseases 8 (4) (2022)
Charles E Mowbray, Stéphanie Braillard, Paul A Glossop, Gavin A Whitlock, Robert T Jacobs, Jason Speake, Bharathi Pandi, Bakela Nare, Louis Maes, Vanessa Yardley, Yvonne Freund, Richard J Wall, Sandra Carvalho, Davide Bello, Magali Van den Kerkhof, Guy Caljon, Ian H Gilbert, Victoriano Corpas-Lopez, Iva Lukac, Stephen Patterson, Fabio Zuccotto, Susan Wyllie
DNDI-6148: A Novel Benzoxaborole Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of medicinal chemistry 64 (21) (2021)
Jean-Olivier Zirimwabagabo, Ameera B A Jailani, Paris Avgoustou, Matthew J Tozer, Karl R Gibson, Paul A Glossop, James E J Mills, Roderick A Porter, Paul Blaney, Ning Wang, Timothy Michael Skerry, Gareth Owain Richards, Joseph P A Harrity
Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization. Journal of medicinal chemistry 64 (6) (2021)